Mary Zupanc, MD
Mary Zupanc, MD is a professor in the Departments of Pediatrics and Neurology at the University of California-Irvine. She also serves as the Division Chief of Pediatric Neurology at UCI/Children’s Hospital of Orange County, Director of the Pediatric Comprehensive Epilepsy Program, and Program Director for the UCI Pediatric Neurology Residency Program.
Dr. Zupanc received her undergraduate degree in Zoology from the University of Wisconsin-Madison in 1974, then carried out a year of research in genetics in Los Angeles before entering UCLA medical school and completing her medical degree in 1979. She completed pediatric residency training at the University of Washington and Harbor–UCLA Medical Center and pediatric neurology training at the University of Wisconsin-Madison under the mentorship of Dr. Raymond Chun. She has subsequently been in the epilepsy divisions at the Mayo Clinic, Columbia University, the Medical College of Wisconsin, and most recently, University of California-Irvine, collaborating with colleagues to develop pediatric epilepsy programs.
Dr. Zupanc is board certified in Pediatrics, Neurology with special competency in Child Neurology, Clinical Neurophysiology, and Epilepsy. She has published articles on a variety of topics, including neonatal seizures, infantile spasms, pediatric epilepsy surgery, and the efficacy of felbamate in intractable pediatric epilepsy. Dr. Zupanc has also authored book chapters on pediatric epilepsy surgery and reproductive health in adolescent girls with epilepsy.
Dr. Zupanc has been a member of the Child Neurology Society and the American Epilepsy Society since the early 1980s. In 2016 she was elected by her colleagues to serve a two-year term on the Board of Directors as Councillor for the West. She has also been active in the American Epilepsy Society, serving as the co-chairperson for the Women with Epilepsy Special Interest Group and on the Nominating Committee. As a member of the Professors of Child Neurology for many years, she collaborated with others in the development of a formal pediatric neurology curriculum for residents. In addition, she has been active in the American Academy of Neurology and the American Board of Psychiatry and Neurology, including recent service on the ABPN Maintenance of Certification Committee and on the United Council of Neurological Subspecialties.
Elizabeth Berry-Kravis, MD, PhD
Dr. Elizabeth Berry-Kravis, M.D., Ph.D. serves as Professor of Pediatrics, Neurological Sciences and Biochemistry at Rush University. Dr. Berry-Kravis established the comprehensive Fragile X Clinic and Research Program at Rush University Medical Center in 1992, through which she provides care and support to over 400 patients with Fragile X Syndrome (FXS) for management of neurological, medical, behavioral and genetic issues. Her clinical research projects involve studies of epilepsy and psychopharmacology in Fragile X, clinical trials of new promising medications in FXS and development of outcome measures and biomarkers for such trials in the FXS population. She has been Member of Scientific Advisory Board at Vtesse, Inc. since October 22, 2015. She completed a pediatrics residency in 1987 and pediatric neurology fellowship in 1990, also at the University of Chicago, and moved to Rush University Medical Center in 1992. She received a Bachelor’s degree in chemistry from the University of Notre Dame in 1979, a Ph.D. in biochemistry in 1983 and M.D. in 1985 from the University of Chicago.
In April 2016, Dr. Berry-Kravis was presented the Sidney Carter Award at the American Academy of Neurology Annual Meeting in Vancouver, BC.